PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,404 | -1.9% | 2,183 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,666 | -34.2% | 2,183 | -8.5% | 0.00% | 0.0% |
| Q4 2022 | $20,767 | -26.9% | 2,387 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,405 | -16.5% | 2,387 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,015 | -14.8% | 2,387 | +24.5% | 0.00% | 0.0% |
| Q1 2022 | $39,912 | -78.7% | 1,917 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $187,664 | -22.5% | 8,124 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $242,095 | +68.9% | 8,124 | +86.4% | 0.00% | +100.0% |
| Q1 2021 | $143,368 | -46.5% | 4,359 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $268,122 | – | 4,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |